Abstract:RATIONALE Universally, the most common method of embedding dissected or resected fresh frozen (FF) tissues is within optimal cutting temperature (OCT) media. Unfortunately, OCT is not ideal for mass spectrometry (MS) assays. The media perfuses through tissues, resulting in persistent polymer contamination causing issues for sensitive analyses. Complete removal of all OCT media background would enable techniques such as MS imaging (MSI) to be bridged to clinically relevant samples stored in biobanks which possess extensive medical histories. Even though methods have been outlined for spatial lipidomics and proteomics, many still avoid these tissues despite vast potential for biological discoveries applying MS or MSI. METHODS Reference FF human pancreas was prepared within OCT media and cryosectioned for matrix-assisted laser desorption/ionization (MALDI)-MSI. Sample preparation protocols using aqueous ammonium formate for spatial lipidomics, and a variety of solutions for fixation, delipidation, and salt removal enabled spatial proteomics as well. MSI was performed on a UHMR HF Orbitrap MS detected broad classes of lipids and intact proteins, enabling an assessment of polymer perfusion and signal delocalization over a broad mass range to evaluate any deleterious artifacts. RESULTS We observe lower polymer contamination from OCT tissues with ammonium formate washes as expected, with several caveats. This was most effective in negative ion mode, where in tandem with the boosted lipid signal positive results were achieved for phospholipids (600-900 Da) and higher mass lipids (>1250 Da). Positive ion mode analyses can be completed for phospholipids, but the condensation of alkali adducts to protonated forms not only increased lipid signals, but also increased signals of larger, persistent PEG oligomers (>1250 Da) which were not previously reported. Even with extensive tissue washing completing a spatial proteomics protocol, the removal of all remnant artifacts of OCT media was not feasible. CONCLUSIONS The finding of these persistent remnant polymers from the OCT embedding process has several consequences for MSI, directly effecting primary performance of the MALDI source and lipid and protein analyses. This does not mean OCT tissues should not be or cannot be used for spatial omics by MSI, but several quality control and quality assurance measures should be implemented, and we discuss paths forward and several considerations.

Site‐to‐Site Reproducibility and Spatial Resolution in MALDI–MSI of Peptides from Formalin‐Fixed Paraffin‐Embedded Samples

Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections

High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue

Cross-Normalization of MALDI Mass Spectrometry Imaging Data Improves Site-to-Site Reproducibility

Selected protein monitoring in histological sections by targeted MALDI-FTICR in-source decay imaging

Optimized protocol for MALDI MSI of N-glycans using an on-tissue digestion in fresh frozen tissue sections

Mass spectrometry imaging protocol for spatial mapping of lipids, N ‐glycans and peptides in murine lung tissue

Recent developments of novel matrices and on-tissue chemical derivatization reagents for MALDI-MSI

Identification of remnant OCT media artifacts after tissue washing by MALDI mass spectrometry imaging

Comparison between enhanced MALDI in-source decay by ammonium persulfate and N- or C-terminal derivatization methods for detailed peptide structure determination.

Egg White as a Quality Control in Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI-MSI)

Improvement of Sensitivity and Reproducibility for Imaging of Endogenous Metabolites by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry

Mass Spectrometry Imaging Using Dynamically Harmonized FT-ICR at Million Resolving Power: Rationalizing and Optimizing Sample Preparation and Instrumental Parameters

MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology

MALDI-IHC-Guided In-Depth Spatial Proteomics: Targeted and Untargeted MSI Combined

Overlapping MALDI-Mass Spectrometry Imaging for In-Parallel MS and MS/MS Data Acquisition without Sacrificing Spatial Resolution

Characterizing the spatial distribution of dipeptides in rodent tissue using MALDI MS imaging with on-tissue derivatization

rMSIfragment: improving MALDI-MSI lipidomics through automated in-source fragment annotation

Optimized Mass Spectrometry Analysis Workflow with Polarimetric Guidance for ex vivo and in situ Sampling of Biological Tissues

On-tissue dataset-dependent MALDI-TIMS-MS2 bioimaging

The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations